In contrast, the expression of B cell lymphoma 2 (Bcl2), B cell lymphoma‐ extra-large (Bcl-xl), and microRNA-21 (miR-21), which are linked to the aggressiveness of MTC, was significantly reduced. The gene discussed is BCL2L1; the disease is medullary thyroid gland carcinoma.